Mesoblast (MESO) Net Debt Issuances and Repayments (2017 - 2021)
Mesoblast (MESO) posted quarterly Net Debt Issuances and Repayments of -$743000.0 for Q3 2021, down 111.36% year-on-year from $6.5 million in Q3 2020, and down 74.0% on a QoQ basis from -$427000.0 in Q2 2021.
Mesoblast (MESO) Net Debt Issuances and Repayments (2017 - 2021) Analysis & Trends
Mesoblast (MESO) has reported Net Debt Issuances and Repayments for 5 consecutive years, with -$743000.0 the latest figure, recorded in Q3 2021.
- Quarterly Net Debt Issuances and Repayments fell 111.36% year-over-year to -$743000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $107.2 million (down 25.37% YoY) and the FY2021 annual result came in at $114.5 million, down 16.48% from the prior year.
- Net Debt Issuances and Repayments fell to -$743000.0 in Q3 2021 per MESO's latest filing, from -$427000.0 in the prior quarter.
- Over the last five years, Net Debt Issuances and Repayments for MESO reached as high as $107.7 million in Q1 2021 and fell as low as -$1.0 million in Q2 2018.
- A 5-year average of $21.7 million and a median of $3.6 million in 2020 frame the typical range for Net Debt Issuances and Repayments.
- Annual changes were most pronounced in 2018 — Net Debt Issuances and Repayments slumped 1064.76% — and 2020, when it surged 269539.39%.
- Year by year, Net Debt Issuances and Repayments stood at -$519000.0 in 2017, then surged by 3943.74% to $19.9 million in 2018, then soared by 141.77% to $48.2 million in 2019, then sank by 98.68% to $638000.0 in 2020, then slumped by 216.46% to -$743000.0 in 2021.
- According to Business Quant data, Net Debt Issuances and Repayments over the past three periods registered -$743000.0, -$427000.0, and $107.7 million for Q3 2021, Q2 2021, and Q1 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -743,000.00 |
| Sep 30, 2021 | -743,000.00 |
| Jun 30, 2021 | -427,000.00 |
| Jun 30, 2021 | -427,000.00 |
| Mar 31, 2021 | 107.71 Mn |
| Mar 31, 2021 | 107.71 Mn |
| Dec 31, 2020 | 638,000.00 |
| Dec 31, 2020 | 638,000.00 |
| Sep 30, 2020 | 6.54 Mn |
| Sep 30, 2020 | 6.54 Mn |
| Jun 30, 2020 | 88.92 Mn |
| Jun 30, 2020 | 88.92 Mn |
| Mar 31, 2020 | -65,000.00 |
| Mar 31, 2020 | -65,000.00 |
| Dec 31, 2019 | 48.23 Mn |
| Dec 31, 2019 | 48.23 Mn |
| Sep 30, 2019 | -36,000.00 |
| Sep 30, 2019 | -36,000.00 |
| Jun 30, 2019 | -33,000.00 |
| Jun 30, 2019 | -33,000.00 |